The biotechnology industry is comprised of all organizations
involved in the development,
manufacturing, or marketing of products that are based on bio-molecular
research. The industry
is closely aligned with the research and development aspect of the pharmaceuticals
industries, which generate the bulk of industry revenues.
In North Carolina, the biotechnology industry has grown up around the
Research Triangle Park
(RTP), an office park located between Durham and Raleigh that was built
in the late 1950s.
The National Institute of Environmental Health Sciences, GlaxoSmithKline,
and other large pharmaceutical and biotechnology companies have had a
presence at RTP.
Nearby universities and an extensive community college system have fed
the industries need for
highly skilled scientists and business representatives.
1950s-1960s: North Carolina invested in Research Triangle
Park (RTP), providing cheap
land and other incentives for companies to build facilities.
The National Institute of Environmental
Health Sciences was located there in the 1960s and
increased the biotechnology’s attraction to RTP.
1970s-1980s: North Carolina continued to offer tax incentives
and supportive organizations
to draw businesses into RTP. The North
Carolina Biotechnology Center (NCBC) was created by
the state’s General Assembly in 1981. This
center was the nation’s first state-sponsored initiative
to develop biotechnology.
1990s-present: North Carolina has seen scientific breakthroughs
in thermoelectric research,
long-range planning for the future of the
biotechnology industry, interdisciplinary coordination
and communication, and a continued investment
by industry, government, and non-profit
organizations that do work related to biotechnology.
In 2000, the state created the Charlotte
Research Institute in an attempt to replicate RTP’s